Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials

2020 ◽  
Vol 14 (4) ◽  
pp. 715-722
Author(s):  
Awadhesh Kumar Singh ◽  
Ritu Singh
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Meta Analysis ◽  
Cardiovascular Outcomes ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials

Endocrine ◽  
2019 ◽  
Vol 65 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Dario Giugliano ◽  
Maria Ida Maiorino ◽  
Miriam Longo ◽  
Giuseppe Bellastella ◽  
Paolo Chiodini ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials

GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

2018 ◽  
Vol 35 (1) ◽  
pp. e3082 ◽  
Author(s):  
Marco Castellana ◽  
Angelo Cignarelli ◽  
Francesco Brescia ◽  
Luigi Laviola ◽  
Francesco Giorgino
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Receptor Agonist ◽  
Meta Analysis ◽  
Bolus Insulin ◽  
Basal Bolus
Sign in / Sign up

Export Citation Format

Share Document